Previous 10 | Next 10 |
Quarterly investor call and webcast scheduled for Monday, February 14 at 8:00 a.m. ET Roivant will also present at the SVB Leerink Global Healthcare Conference in February, and the Truist AI Symposium and Cowen Healthcare Conference in March BASEL, Switzerland and LONDO...
Plans to initiate phase 3 study using batoclimab for the treatment of patients with myasthenia gravis expected 1st half of 2022. Two additional indications in the pipeline will be announced in August of 2022. Goal to choose two additional indications with the use of batoclimab to ...
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced that its CEO Matt Gline will present at two upcoming conferences: B. Riley Securities Virtual Oncology Conference on Thursday, January 27, 2022 at...
Roivant will develop RVT-2001 for the treatment of transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes Roivant JPM presentation scheduled for Monday, January 10, at 2:15 p.m. ET BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Jan. 05, 2022 (...
ROIV has moved up 88% in December in reaction to a patent dispute between Moderna and Arbutus falling in favor of Arbutus. The patent is licensed to a private company called Genevant. ROIV owns an effective 88% stake through direct ownership and its stake in ABUS. ROIV's move upwa...
Gainers: Society Pass (NASDAQ:SOPA) +237%. Bluerock Residential Growth (NYSE:BRG) +71%. Can-Fite (NYSE:CANF) +59%. AeroClean (NASDAQ:AERC) +58%. Galera Therapeutics (NASDAQ:GRTX) +38%. Verso (NYSE:VRS) +35%. Roivant (NASDAQ:ROIV) +26%. Venus (NASDAQ:VERO) +25%. BioCardia (NASDAQ:BCDA) +1...
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) traded at a new 52-week high today of $16.63. So far today approximately 466,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares. Roivant Sciences Ltd is a biopharmaceutical company dedicated to impro...
Roivant Sciences (ROIV +16.2%) has gained for the fifth straight session on above average volume extending its December rally to nearly 90%. Its share volatility led to a brief trading halt in morning hours. Over 2.3M Roivant (NASDAQ:ROIV) shares have changed hands so far compared to 65-day a...
The healthcare stocks in the S&P 500 with a ~2.5% gain outperformed all other sectors in the broader index thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%. Am...
SAN DIEGO, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Nanome , the first virtual reality software company to launch an immersive real-time collaboration platform for scientific discovery, today announced that the company has executed its largest deployment to date with Roivant Discovery ...
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
Roivant Sciences Ltd. Website:
2024-07-11 10:45:04 ET Rivian Automotive Inc (RIVN) RIVN is trading UP for the last 5 days, and it at trading at $16.74 with volume of 18,885,597 and a one day change of $0.37 (2.23%). Rivian Automotive Inc has a 52-week low of 12.15 and a 52-week high of $32.60. The business's 50-d...
2024-06-02 17:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...